SCHEMBL9963607

SCHEMBL9963607

Cc1c2nc(NCC(=O)N3CCN(C4CCCC4)CC3)sc2cc2sc(NCC(=O)N3CCCC(F)(F)C3)nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.38
BCHE P06276 1/20 0.38
GRIN2B Q13224 1/20 0.38
ALDH1A1 P00352 5/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 1/20 0.35
CHRM4 P08173 1/20 0.35
PTGS2 P35354 4/20 0.35
HPGD P15428 1/20 0.34
TLR9 Q9NR96 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
KDM4E B2RXH2 2/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963658 0.93 TP53 (0.42) ACHEBCHEGRIN2BALDH1A1L3MBTL1
SCHEMBL9963580 0.89 ACHE (0.45) ACHEBCHEGRIN2BALDH1A1LMNA
SCHEMBL9963639 0.89 PTGS2 (0.44) L3MBTL1CHRM4PTGS2TLR9TLR8
SCHEMBL9963585 0.88 BCHE (0.45) ACHEBCHEGRIN2BALDH1A1LMNA
SCHEMBL9963661 0.87 LIPG (0.35) ACHEBCHEGRIN2BTP53CHRM4
SCHEMBL9963672 0.87 PTGS2 (0.38) CHRM4PTGS2TLR9TLR8TLR7
SCHEMBL9963641 0.86 CHRM4 (0.35) LMNATP53CHRM4PTGS2TLR9
SCHEMBL9963550 0.86 ACHE (0.42) ACHEBCHEGRIN2BALDH1A1LMNA
SCHEMBL14369905 0.85 PTGS2 (0.36) ACHEBCHEGRIN2BALDH1A1L3MBTL1
SCHEMBL9963654 0.85 PTGS2 (0.39) ALDH1A1POLBCHRM4PTGS2TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 ACHE 1479/4885BCHE 3319/4885GRIN2B 4012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.